[
  {
    "ts": null,
    "headline": "Bullish On Akeso's Ivonescimab, But Valuation And Geopolitical Risks Remain",
    "summary": "Bullish On Akeso's Ivonescimab, But Valuation And Geopolitical Risks Remain",
    "url": "https://finnhub.io/api/news?id=fbbac23106853f09cc784df655d7fc75507e2a17400ed3b710c56f6a5bf6600d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745144100,
      "headline": "Bullish On Akeso's Ivonescimab, But Valuation And Geopolitical Risks Remain",
      "id": 133978411,
      "image": "",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=fbbac23106853f09cc784df655d7fc75507e2a17400ed3b710c56f6a5bf6600d"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly: A New Leader In Weight Loss Drugs Is Clearly Emerging",
    "summary": "Eli Lilly: A New Leader In Weight Loss Drugs Is Clearly Emerging",
    "url": "https://finnhub.io/api/news?id=5c7a3e11ff066e7d1879dae30f02f6254ad7f89cd4e23686c001138be2135afd",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745139600,
      "headline": "Eli Lilly: A New Leader In Weight Loss Drugs Is Clearly Emerging",
      "id": 133978061,
      "image": "",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=5c7a3e11ff066e7d1879dae30f02f6254ad7f89cd4e23686c001138be2135afd"
    }
  }
]